Gene interactions and pathways from curated databases and text-mining

◀ Back to PRKAG1

CAMKK1 — PRKAG1

Pathways - manually collected, often from reviews:

Text-mined interactions from Literome

Jensen et al., Am J Physiol Endocrinol Metab 2007 : Possible CaMKK dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction
Witczak et al., Diabetes 2007 : The objective of this study was to determine whether CaMKKalpha regulates skeletal muscle glucose uptake, and whether it is dependent on AMPK and/or Akt activation
Jensen et al., Am J Physiol Endocrinol Metab 2007 (Calcium Signaling) : We conclude that a SR Ca ( 2+ ) -activated CaMKK may control alpha ( 1 ) -AMPK activation and be necessary for caffeine stimulated glucose uptake in mouse soleus muscle
Shen et al., Am J Physiol Cell Physiol 2007 : In addition, ALA treatment increased the association of AMPK with CaMKK ... To further show the role of CaMKK in AMPK activation, short interfering RNA was used to silence CaMKK, which abolished the ALA induced AMPK activation
Mount et al., Atherosclerosis 2008 : Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK dependent activation of AMPK ... In conclusion, BK stimulates endothelial cell fatty acid oxidation by CaMKK dependent activation of AMPK
Jorgensen et al., Frontiers in bioscience : a journal and virtual library 2008 : Specifically, the role of LKB1 and phosphatase PP2C in nucleotide dependent activation of AMPK, and ionized calcium in CaMKK dependent activation of AMPK in working muscle is discussed
Thors et al., Biochim Biophys Acta 2008 : In contrast, under culture conditions that do not facilitate a fall in ATP after stimulation, AMPK activation is exclusively mediated by CaMKK and does not contribute to the phosphorylation of eNOS
Lee et al., Bone 2010 (Bone Resorption) : AMPK negatively regulates RANKL, possibly by acting through CaMKK and TAK1
Hsu et al., J Pharmacol Exp Ther 2011 : 7H-benz [ de ] benzimidazo [ 2,1-a ] isoquinoline-7-one-3-carboxylic acid acetate ( STO-609 ), a calmodulin kinase kinase ( CaMKK ) inhibitor, reduced the level of expression of CYP4F2 elicited by genistein, suggesting that CaMKK activation contributed to AMPK activation by genistein
Kawashima et al., PloS one 2012 (Hypoglycemia) : However, the involvement of CaMKK in neuroglucopenia induced activation of AMPK in the hypothalamus has not been tested ... To determine whether neuroglucopenia induced AMPK activation is mediated by CaMKK , we tested whether STO-609 ( STO ), a CaMKK inhibitor, would block the effects of 2-deoxy-D-glucose ( 2DG ) -induced neuroglucopenia both ex vivo on brain sections and in vivo ... In conclusion, activation of hypothalamic AMPK by 2DG induced neuroglucopenia is not mediated by CaMKK
Morotomi-Yano et al., Biochem Biophys Res Commun 2012 : In LKB1-deficient cells, AMPK activation by nsPEFs was mediated by CaMKK and required extracellular Ca ( 2+ ), which suggested the occurrence of Ca ( 2+ ) mobilization and its participation in AMPK activation by nsPEFs